Cost of cancer clinical trials in elderly patients

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 3, 2004, Pages 505-511

  Balducci, Lodovicco ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Clinical trials; Cost; Elderly

Indexed keywords

ANTHRACYCLINE; CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ERYTHROPOIETIN; GEMCITABINE; LIPOSOME; MORPHINE; NAVELBINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OPIATE; PLATINUM; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

AGED; CANCER THERAPY; CAUSE OF DEATH; CLINICAL TRIAL; CONSTIPATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DRUG COST; ELDERLY CARE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; NAUSEA; PATIENT CARE; PATIENT SELECTION; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; HUMANS; NEOPLASMS;

EID: 1542505516     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.3.505     Document Type: Review

References (51)

1. YANCIK RM,MRIES L: Cancer and age: magnitude of the problem. In: Comprehensive Geriatric Oncology. Balducci L, Lyman GH, Ershler WB. Harwood Academic Publishers, London, (1998).
2. REPETTO L, BALDUCCI L: A case for geriatric oncology. Lancet Oncol. (2002) 3(5):289-297.
3. ANONYMOUS: Integrating economic analysis into cancer clinical trials: The National Cancer Institute - American Society of Clinical Oncology workbook. J. Natl. Cancer Inst. Monographs (1998) 24:1-28.
4. ROBINSON B: Cost of anemia in the elderly. J. Am. Ger. Soc. (2003) 51(3 Suppl.):S14-S17.
5. LUBITZ J, CAI L, KRAMAROW E et al.: Health, life-expectancy and health care spending among the elderly. N. Engl. J. Med. (2003) 349:1048-1055.
6. BALDUCCI L, HARDY CL, LYMAN GH: Hematopoietic growth factors in the older cancer patient. Curr. Opin. Hematol. (2001) 8(3):170-187.
7. HAYMAN JA, LANGA KM, KABETO MU et al.: Estimating the cost of informal caregiving for elderly patients with Cancer. J. Clin. Oncol. (2001) 19:3219-3225.
8. SOLDO BJ, HURD MD, RODGERS WL et al.: Asset and health dynamics among the oldest old: An overview of the AHEAD Study. J. Gerontol. B Psychol. Sci. Soc. Sci. (1997) 52B:1-20.
9. HALEY WE, BURTON AM, LAMONDE LA, SCHONWETTER RS: Family caregiving for older cancer patients. In: Comprehensive geriatic oncology (2nd edn). Balducci L, Lyman GH, Ershler WB, Extermann M (Eds.), Harwood Academic Publishers, London (In Press).
10. HALEY WE, BURTON AM, LAMONDE LA, SCHONWETTER RS: Predictors of depression and life satisfaction among spousal caregivers in hospice: application of a stress process model. J. Palliat. Med. (2003) 6:215-224.
11. OVERCASH J, BALDUCCIAL: The older cancer patient: a guide for nurses and related professionals. Springer Publishing Company, New York, USA (2003).
12. GOODWIN PJ, SHEPHERD FA: EAonomic issues in lung cancer: a review. J. Clin. Oncol. (1998) 16.3900-3912.
13. FISHER RI, GAYNOR ER, DAHLBER S et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced Non Hodgkin's Lymphoma. N. Engl. J. Med. (1993) 318:1002-1006.
14. TALLMAN MS, GRAY R, ROBERT NJ et al.: Conventional adjuvant chemotherapy with or without high dose chemotherapy and autologous stem cell rescue in high risk breast cancer. N. Engl. J. Med. (2003) 349:17-26.
15. BENNETT CL,AADAMS JR, KNOX KS et al.: Clinical Trials: are they a good buy? J. Clin. Oncol. (2001) 19:4330-4339.
16. DU W, REEVES JH, GADGEEL S et al.: Cost-effectiveness and lung cancer clinical trials. Cancer (2003) 98:1491-1496.
17. BENNETT CL, STINTSON TJ, VOGEL V et al.: Evaluating the financial impacts of clinical trials in oncology: Results from a pilot study from the association of American Cancer Institutes. J. Clin. Oncol. (2000) 18:2805-2810.
18. FIREMAN BH, FEHERENBACHER L, GRUSKIN EP et al.: Cost of care for patients in cancer clinical trials. J. Natl. Cancer Inst. (2000) 92:136-142.
19. GOLDMAN DP, BERRY SH, MCCABE MS et al.: Incremental Treatment costs in national cancer institute-sponsored clinical trials. JAMA (2003) 289(22):2970-2977.
20. ANONYMOUS: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. Advanced colorectal Cancer meta-analysis. J. Clin. Oncol. (1992) 10:896-903.
21. KHANSUR T, HAICK A, PATEL B et al.: Preoperative evaluation with radionuclide brain scanning and computerized Axial Tomography of the brain in patients with breast cancer. Am. J. Surg. (1988) 155:232-234.
22. EXTERMANN M, BALDUCCI L, LYMAN GH: What threshold for adjuvant therapy in older breast cancer patients? J. Clin. Oncol. (2000) 18:1709-1717.
23. MORRISON VA, PICOZZI V, SCOTTI S et al.: The impact of age on delivered dose-intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's Lymphoma receiving initial CHOP chemotherapy: A risk factor analysis. Clin. Lymphoma (2001) 2:47-56.
24. CHRISCHILLES E, DELGADO DI, STOLSHEK BS et al.: Impact of age and colony stimulating factor use in hospital length of stay for febbrile neutropenia in CHOP treated non-Hodgkin's lymphoma patients. Cancer Control (2002) 9:203-211.
25. REPETTO L, FRATINO L, AUDISIO RA et al.: Comprehensive geriatric assessment adds information to the Eastern Cooperative Group performance status in elderly cancer patients. An Italian Group for Geriatric Oncology Study. J. Clin. Oncol. (2002) 20:494-502.
26. INGRAM SS, SEO PH, MARTELL RE et al.: Comprehensive assessment of the elderly cancer patient: The feasibility of self-report methodology. J. Clin. Oncol. (2002) 20:770-775.
27. EXTERMANN M, OVERCASH J, LYMAN GH et al.: Comorbidity and functional status are independent in older cancer patients. J. Clin. Oncol. (1998) 16:1582-1587.
28. SALIBA D, ELLIOTT M, RUBENSTEIN LZ et al.: The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. J. Am. Ger. Soc. (2001) 49:1691-1699.
29. PODSIADLO D ANDARICHARDSON S: The timed 'up & go': a test of basic functional mobility for frail elderly persons. J. Am. Ger. Soc. (1991) 39:142-148.
30. RINK L, CA KMAN I, KIRCHNER H: Altered cytokine production in the elderly. Mech. Ageing Dev. (1998) 102:199-209.
31. COHEN HJ, HARRIS T, PIEPER CF: Coagulation and activation of the inflammation pathway in the development of functional decline and mortality in the elderly. Am. J. Med. (2003) 114:180-187.
32. EMANUEL E: HeaSth care reform: still possible? Hastings Center Rep. (2002) 32:32-34.
33. BEGG CB, CARBONE P: Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer (1983) 52:1986-1992.
34. HUTCHINS LF, UNGER JM, CROWLEY JJ et al.: Underrepresentation fo patients 65 year of age or older in cancer treatment trials. N. Engl. J. Med. (1999) 341:2061-2067.
35. LEWIS JH, KILGORE ML, GOLDMAN DP et al.: Participation of patients 65 year of age and older in cancer clinical trials. J. Clin. Oncol. (2003) 21:1383-1388.
36. KEMENY MN, PETERSON BL, KOMBLITH AB et al.: Barriers to clinical trial participation by older women with breast cancer. J. Clin. Oncol. (2003) 21:2269-2279.
37. ZINZANI PG, STORTI S, ZACCARIA A et al.: Elderly aggressive histology Non-Hodgkin'E Lymphoma: First line VNCOP-B regimen: expereince on 350 patients. Blood (1999) 94:33-38.
38. SONNEVELD P, DE RIDDER M, VAN DER LELIE H et al.: Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lyphoma using CHOP versus CNOP chemotherapy. J. Clin. Oncol. (1995) 13:2530-2539.
39. TIRELLI TIRELLI U, ERRANTE D, VAN GLABBEKE M et al.: CHOP is the standard regimen in patients ≥ 70 years of age with intermediate and high grade Non-Hodgkin's lymphoma: Results of a randomized study of the European organization for the Research and Treatment of Cancer Lymphoma Cooperative Study. J. Clin. Oncol. (1998) 16:27-34.
40. BASTION Y, BLAY J-Y, DIVINE M et al.: Elderly patients with aggressive non-Hodgkin's lymphoma: Disease presentation, response to treatment and survival. A Groupe d'Etude des Lymphomes de l'Adulte Study on 453 patients older than 69 years. J. Clin. Oncol. (1997) 15:2945-2953.
41. OSBY E, HAGBERG H, KVALOY S et al.: CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: Results of a Nordic Lymphoma Group randomized trial. Blood (2003) 101:3840-3848.
42. LANCET JE, Willman CL, Bennett JM: Acute Myelogenous Leukemia and aging: Clinical Interactions. Hematol./Oncol. Clinics N. America (2000) 16:251-268.
43. HAYMAN J, SCHNITT S, GELMAN R et al.: A prospective trial of conservative surgery (CS) alone without radiation therapy (RT) in selected patients with early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. (1995) 32(Suppl. 1):209.
44. WYCKOFF J, GREENBERG H, SANDERSON R et al.: Breast irradiation in the older woman: A toxicity study. J. Am. Ger. Soc. (1994) 42:153-156.
45. MORROW M, HARRIS JR. SCHNITT SJ: Local control following breast cancer conserving surgery: Results of clinical trials. J. Natl. Cancer Inst. (1995) 87:1669-1673.
46. WOLMAKR N, DIGNAM J, MARGOLESED et al.: The role of radiotherapy and tamoxifen in the management of node-negative breast cancer - 1.0 cm treated with lumpectomy: Preliminary results of NSABP protocol B21. Proc. ASCO (2000) 19:70a (Abstract 271).
47. MUSTACCHI G, MILANI S, PLUCHINOTTA A: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Res. (1994) 14(5B):2197-2200.
48. BALDUCCI L: Pain management in elderly cancer patients. J. Supp. Oncol. (2003).
49. SMITH TJ, ROTHEMBERG SS, BROOKS M et al.: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for cancer pain: Impact on pain, drug-related toxicity, and survival. J. Clin. Oncol. (2002) 20:4040-4049.
50. RAVDIN PM; SMIRNOFF LA, DAVIS GJ et al.: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J. Clin. Oncol. (2001) 19:980-981.
51. LYMAN GH, KUDERER N, AGBOOLA O et al.: Evidence-based use of colony-stimulating factors in elderly cancer patients. Cancer Control (2003) 10:487-499.